Intriguingly, cancer cells treated with inhibitors of the mitotic kinase Plk1 or the chemotherapeutic drugs abiraterone or Taxol also underwent entosis due to mitotic disruption, suggesting that this mechanism could have clinical significance in cancer therapy30. Here, PLK1 is linked to cancer.